Is CombiGene AB (publ) (COMBI.ST) a Buy, Sell, or Hold?
STO : COMBI.ST
CombiGene AB (publ)
$2.47 SEK
-$0.1 (-3.89%)
- Volume
- 8.16K
- Average Volume
- 22.91K
- Market Capitalization
- $48.91M
- P/E Ratio
- -3.98
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.18
- Year Low
- $1.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.36
Company Overview
STO
Peter Ekolind
Biotechnology
Healthcare
COMBI.ST
9
SE
SEK
Liquidity Metrics
0.00
10.36
10.36
10.21
0.00
Sales & Valuation
$326K
-205.50
0.88
-5.15
-0.48
Profitability
-$2.27
-$44.88M
5184.45%
5184.45%
-22.32%
-20.17%
P/E Metrics
-3.98
0.88
0.88
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
0.14
3/9
$55.28M
$61.19M
$5.91M
-$38.26M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Annika Ericson | Chief Scientific Officer |
| Louise Aspenberg | Chief Financial Officer |
| Peter Ekolind | Chief Executive Officer |
Poll Results
No votes yet today — be the first to share your view!
About CombiGene AB (publ) (STO:COMBI.ST) Stock
Headquartered in Lidingö, Sweden, CombiGene AB (publ) was established in 1999 and specializes in pioneering gene therapy solutions for severe, life-altering medical conditions. The company is currently advancing two primary gene therapy candidates in its pipeline. CG01, a treatment targeting epilepsy, is undergoing preclinical trials that include detailed biodistribution and toxicology assessments. Its second candidate, CGT2, is under development for addressing lipodystrophy. CombiGene also maintains strategic alliances, including a licensing and collaborative agreement with Lipigon Pharmaceuticals AB to create a gene therapy for partial lipodystrophy, and a partnership with Spark Therapeutics for the advancement of adeno-associated virus (AAV) based gene therapies. ...
Frequently Asked Questions
-
What is the current CombiGene AB (publ) (COMBI.ST) stock price?
-
CombiGene AB (publ)(STO:COMBI.ST) stock price is $2.47 in the last trading session. During the trading session, COMBI.ST stock reached the peak price of $3.18 while $1.27 was the lowest point it dropped to. The percentage change in COMBI.ST stock occurred in the recent session was --3.89% while the dollar amount for the price change in COMBI.ST stock was -$0.1.
-
COMBI.ST's industry and sector of operation?
-
The STO listed COMBI.ST is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of COMBI.ST?
-
Annika Ericson | Chief Scientific Officer
Louise Aspenberg | Chief Financial Officer
Peter Ekolind | Chief Executive Officer
|
| -
How many employees does COMBI.ST have?
-
Number of COMBI.ST employees currently stands at 9. COMBI.ST operates from Agavagen 52A, Lidingö, None 181 55, SE.
-
Link for COMBI.ST official website?
-
Official Website of COMBI.ST is: https://www.combigene.com
-
How do I contact COMBI.ST?
-
COMBI.ST could be contacted at phone #46 7 04 66 31 63 and can also be accessed through its website. COMBI.ST operates from Agavagen 52A, Lidingö, None 181 55, SE.
-
How many shares of COMBI.ST are traded daily?
-
The average number of COMBI.ST shares traded daily for last 3 months was 22.91K.
-
What is the market cap of COMBI.ST currently?
-
The market value of COMBI.ST currently stands at $48.91M with its latest stock price at $2.47